Mitchell & Pahl Private Wealth, LLC Astrazeneca PLC Transaction History
Mitchell & Pahl Private Wealth, LLC
- $207 Million
- Q1 2025
A detailed history of Mitchell & Pahl Private Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mitchell & Pahl Private Wealth, LLC holds 13,651 shares of AZN stock, worth $926,493. This represents 0.48% of its overall portfolio holdings.
Number of Shares
13,651
Previous 13,872
1.59%
Holding current value
$926,493
Previous $908,000
10.46%
% of portfolio
0.48%
Previous 0.44%
Shares
18 transactions
Others Institutions Holding AZN
# of Institutions
1,382Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.1 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.78 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.55 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.63 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $210B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...